日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer

更正:PTUPB 对 AKR1C3 和雄激素受体轴的新型抑制作用可增强恩扎卢胺治疗晚期前列腺癌的效果

Yang, Joy C; Xu, Pengfei; Ning, Shu; Wasielewski, Logan J; Adomat, Hans; Hwang, Sung Hee; Morisseau, Christophe; Gleave, Martin; Corey, Eva; Gao, Allen C; Lara, Primo N Jr; Evans, Christopher P; Hammock, Bruce D; Liu, Chengfei

Editorial: Epigenetics in the microbiome-host crosstalk: from mechanisms to therapeutics

社论:表观遗传学在微生物组-宿主相互作用中的作用:从机制到治疗

Ramos-Lopez, Omar; Liu, Chengfei; Liu, Hao-Yu

IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer

IGFBP3-SphK1/S1P信号轴驱动晚期前列腺癌的恩扎卢胺耐药性

Leslie, Amy R; Ning, Shu; Sharifi, Masuda; Schaaf, Zachary A; Maine, James P; Lou, Wei; Leslie, Kristina D; Liu, Chengfei; Xu, Hongyu; Lombard, Alan P; Chen, Hong-Wu; Parikh, Mamta; Dall'Era, Marc; Gao, Allen C

Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate Cancer.

前列腺癌恩扎卢胺耐药进展过程中免疫相关信号的动态重编程。

Xu Pengfei, Qu Huan, Yang Joy C, Wei Fan, Zhao Junwei, Tang Menghuan, Wang Leyi, Nip Christopher, Li Henson, Gao Allen C, Lam Kit, Dall'Era Marc, Li Yuanpei, Liu Chengfei

Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer.

类固醇硫酸酯酶调节晚期前列腺癌的代谢重编程

Sharifi Masuda, Armstrong Cameron M, Ning Shu, Leslie Amy R, Schaaf Zachary A, Maine James P, Lou Wei, Li Pui-Kai, Xu Hongyu, Liu Chengfei, Gao Allen C

Hyperopic reserve as a predictor of myopia incidence in schoolchildren aged 6-12 years: a 24-month prospective cohort study

远视储备作为6-12岁学龄儿童近视发生率的预测指标:一项为期24个月的前瞻性队列研究

Dong, Wei; Fu, Kunlin; Zhang, Ye; Li, Yangbing; Liu, Chengfei; Wang, Zihao; Li, Yanying; Song, Boyang; Du, Zhaojiang

Development and validation of a risk prediction model related to inflammatory and nutritional indexes for postoperative pulmonary infection after radical colorectal cancer surgery

建立并验证与炎症和营养指标相关的根治性结直肠癌术后肺部感染风险预测模型

Han, Jingxiang; Yao, Tian; Gao, Linna; Gao, Huiyang; Chen, Yuhao; Wang, Yanli; Cao, Yinglei; Liu, Chengfei; Qiu, Fubin; Jia, Kai; Huang, He

Prevalence of astigmatism among 99,515 children in different areas of Xi'an City, China

中国西安市不同地区99515名儿童散光患病率调查

Zhang, Ye; He, Xiaokang; Dong, Wei; Wang, Zihao; Liu, Chengfei; Li, Yanying; Du, Zhaojiang

LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.

LX1 双靶点 AR 变异体和 AKR1C3 在晚期前列腺癌治疗中的应用

Ning Shu, Armstrong Cameron M, Xing Enming, Leslie Amy R, Gao Richard Y, Sharifi Masuda, Schaaf Zachary A, Lou Wei, Han Xiangrui, Xu Desiree H, Yang Rui, Cheng Jeffrey, Mohammed Shabber, Mitsiades Nicholas, Liu Chengfei, Lombard Alan P, Wu Chun-Yi, Cheng Xiaolin, Li Pui-Kai, Gao Allen C

Correction: Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer

更正:尼克酰胺通过抑制去势抵抗性前列腺癌中的雄激素受体变体来增强阿比特龙的治疗效果

Liu, Chengfei; Armstrong, Cameron; Zhu, Yezi; Lou, Wei; Gao, Allen C